Poland – Delivery of the medicinal product Nivolumab + Relatlimab, PN-166/26/TM
By: National Institute of OncologyMaria Skłodowska-Curie - National Research Institute📍 PolandOpen
Key Information
| Reference | GB-803177-2026 |
|---|
| Deadline | Dec 18, 2026 12:00 AM |
|---|
| Category | Advertising & Media |
|---|
| Competition Type | ICB |
|---|
| Funding Source | Self-Funded |
|---|
| Country | Poland |
|---|
| Address | streetW. K. Roentgena 5, Warsaw, 02-781, Poland |
|---|
| Published | Nov 18, 2026 |
|---|
Description
2. Procedure2.1.ProcedureTitle: Dostawa produktu leczniczego Niwolumab + Relatlimab, PN-166/26/TMDescription: 1. Przedmiotem zamówienia jest dostawa produktu leczniczego Niwolumab + Relatlimab.2. Szcz...
Full details are available after unlocking this tender.